K. Papp, “Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies”, J of Skin, vol. 5, no. 1, p. s8, Jan. 2021.